Evidence map›Paper›PMID 37279070›Full record

ReviewMolecular pharmaceutics2023

Natural Ingredients of Transdermal Drug Delivery Systems as Permeation Enhancers of Active Substances through the

Natalia Schafer, Radosław Balwierz, Paweł Biernat, Wioletta Ochędzan-Siodłak, Jacek Lipok

Abstract readReview
In one paragraph

Review in Molecular pharmaceutics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 62 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
62citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

62 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. EnhancedRSC advances · 2026
    Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review

2 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Natalia SchaferFaculty of Chemistry, University of Opole, 45-052 Opole, Poland.
Radosław BalwierzFaculty of Chemistry, University of Opole, 45-052 Opole, Poland.ORCID 0000-0002-6173-2702
Paweł BiernatDepartment of Drug Forms Technology, Faculty of Pharmacy, Wroclaw Medical University, 50-556 Wroclaw, Poland.ORCID 0000-0002-5308-4426
Wioletta Ochędzan-SiodłakFaculty of Chemistry, University of Opole, 45-052 Opole, Poland.ORCID 0000-0002-8226-4362
Jacek LipokFaculty of Chemistry, University of Opole, 45-052 Opole, Poland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In recent years, significant progress has been made in transdermal drug delivery systems, but there is still a search for enhancers that can improve the absorption of active substances through the

Indexed as

SkinSkin AbsorptionAdministration, CutaneousDrug Delivery SystemsEpidermisPharmaceutical VehiclesPharmaceutical Vehiclesfatty acidspenetration enhancerspolysaccharidesraw materialsskin barrierterpenes

Identifiers

PMID37279070
PMCPMC10324402

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.